|
|
9/29/2004 11:54:57 AM ET
SWISS MEDICA EXPANDS MEDIA COVERAGE FOR O24™ ESSENTIAL OIL PAIN NEUTRALIZER PRODUCT TO
MEET CONSUMER DEMAND
FOR IMMEDIATE RELEASE
Stock Symbol: OTC BB: SWME
September 29, 2004
SWISS MEDICA EXPANDS MEDIA COVERAGE FOR O24™ ESSENTIAL OIL PAIN NEUTRALIZER PRODUCT TO
MEET CONSUMER DEMAND
Toronto, Canada – Grant Johnson, President and COO of Swiss Medica, is pleased to announce expanded
media coverage and upcoming events for the Company’s flagship product, the O24™ Essential Oil Pain
Neutralizer, now that the Company is experiencing increasing demand and Canadian retail re-orders for our
product.
Swiss Medica has begun posting an Event Calendar on the Company’s website, which will be regularly updated
with talk show appearances, conferences and events. To see our Calendar, please go to www.swissmedica.com,
click on “Investor Relations", and then click on “Calendar.”
Swiss Medica has also posted a 24-page Investor Information Guide on the Company’s website: www.
swissmedica.com/investorguide.pdf
Starting on October 2nd, Swiss Medica spokesmen will begin appearing on a substantial number of one-hour live
AM radio talk shows in selected Canadian cities. These cities include larger metropolitan areas, such as
Toronto, Montreal, Vancouver, and Ottawa. Smaller cities, such as Halifax (Nova Scotia) and key Ontario cities,
such as Peterborough, Windsor, London and Kitchener-Waterloo, were selected because of strong retail
presence of the O24™ product in those cities. Shareholders may wish to listen to these live radio talk show
appearances via the Internet, where applicable, by visiting the Swiss Medica events calendar and checking times
and dates.
Throughout October, Swiss Medica has contracted to have in-store demonstrations of the O24™ product in 250
leading pharmacies across Canada. This is to help educate pharmacists and consumers about our flagship
product’s different applications for various body ailments.
On October 14th to 16th, Swiss Medica will debut the O24™ product to the US consumer market at the AARP
(American Association of Retired Persons) national event in Las Vegas, Nevada. Dr. E. Michael Gutman will
speak about the O24™ product’s pain relief qualities and efficacy for fibromyalgia and arthritic pains. More than
20,000 AARP members and guests are expected to attend this national event.
About Swiss Medica Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our
market share through focused distribution strategies in multiple sales channels. Swiss Medica’s mission is to be
a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please
visit our websites at www.swissmedica.com and www.024zone.com.
Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the
United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking
statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close
transactions being contemplated, risks related to international sales and potential foreign currency exchange
fluctuations, continued acceptance of Swiss Medica’s products, increased levels of competition, technological
changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica’s
periodic reports filed with the United States Securities and Exchange Commission and other regulatory
authorities.
Investor Relations Contact:
David Jones
Swiss Medica Inc.
1 866 485 4243
djones@swissmedica.com
|
|
